2m 2m 2m 2m 2m 2m 2m
OVID THERAPTCS (OVID)
NASDAQ
$2.35-$0.12 (-4.86%)
Price as of Oct 22, 2026 7:30 PM EDT- $482.4MMarket Cap
- 53.42%1-Year Change
- BiotechnologyIndustry
OVID THERAPTCS (OVID)
$2.35-$0.12 (-4.86%)
OVID | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.47 | ||
Change | +$0.11 (+4.66%) | ||
Open | $2.37 | ||
High | $2.65 | ||
Low | $2.35 | ||
Previous Close | $2.36 | ||
Volume | 5,005,617 | ||
30-Day Average Volume | 1,821,998 | ||
1-Week Change | 12.79% | ||
1-Month Change | -8.86% | ||
1-Year Change | 53.42% | ||
3-Year Change | -28.82% | ||
5-Year Change | -31.77% | ||
Fundamentals | |||
Shares Outstanding | 195.3M | ||
Total Assets | $232.0M | ||
Market Cap | $482.4M | ||
Enterprise Value | $471.1M | ||
Period: QTR TTM FY | |||
Revenue | $733,000.00 | ||
Net Income | -$15.0M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$15.0M | ||
EBITDA | -$15.0M | ||
Net Working Capital | $113.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 643 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue